Well, merely shortening the series from infinity to, say, eight years would make a significant difference in your bottom-line figure. We know that Lovenox is not going to be a blockbuster forever.
No argument, but the point is kind of moot.
Unless you have some real inside knowledge, you are taking a WAG on what MNTA thinks their trial odds are, then backing into a settlement from there. As good as any guess, but obviously MNTA has a much better view come Monday.
Back to Hattie, it is reasonable for MNTA to give up some fair value on the deal. Life is not fair.
News 
Market Data 
Discover 
AI
